Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Meng

Showing results (511-520 of 516) with videos related to

Pageof 52
Sort By:
You have reached the last page of results.This site can display upto 516 results.
Nature|July 21, 2022
Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodiesDami A Collier, Anna De Marco, Isabella A T M Ferreira, et al.
Nature Communications|October 17, 2022
SARS-COV-2 antibody responses to AZD1222 vaccination in West AfricaAdam Abdullahi, David Oladele, Michael Owusu, et al.
Nature|September 6, 2021
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasionPetra Mlcochova, Steven A Kemp, Mahesh Shanker Dhar, et al.
Nature Methods|November 2, 2021
Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysisRebeca Kawahara, Anastasia Chernykh, Kathirvel Alagesan, et al.
Nature Methods|December 11, 2021
Author Correction: Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysisRebeca Kawahara, Anastasia Chernykh, Kathirvel Alagesan, et al.
Nature|February 1, 2022
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicityBo Meng, Adam Abdullahi, Isabella A T M Ferreira, et al.
Pageof 52

Showing results (511-520 of 516) with videos related to

Sort By:
Pageof 52
You have reached the last page of results.This site can display upto 516 results.
Nature|July 21, 2022
Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodiesDami A Collier, Anna De Marco, Isabella A T M Ferreira, et al.
Nature Communications|October 17, 2022
SARS-COV-2 antibody responses to AZD1222 vaccination in West AfricaAdam Abdullahi, David Oladele, Michael Owusu, et al.
Nature|September 6, 2021
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasionPetra Mlcochova, Steven A Kemp, Mahesh Shanker Dhar, et al.
Nature Methods|November 2, 2021
Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysisRebeca Kawahara, Anastasia Chernykh, Kathirvel Alagesan, et al.
Nature Methods|December 11, 2021
Author Correction: Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysisRebeca Kawahara, Anastasia Chernykh, Kathirvel Alagesan, et al.
Nature|February 1, 2022
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicityBo Meng, Adam Abdullahi, Isabella A T M Ferreira, et al.
Pageof 52